Patients were grouped into low- and high-frequency groups based on tumour-infiltrating lymphocytes (TILs) according to a median value of 252/4HPFs for CD3+ TILs, 96/4HPFs for CD8+ TILs, and 0/4HPFs for Foxp3+ TILs. This evidence concerns the gene CD8A and neoplasm.